Vanessa Giannone
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Genetics 4
- Hemoglobinopathies and Related Disorders 4
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Benjamin Besse (3 shared papers)Egbert F. Smit (3 shared papers)Bruce E. Johnson (3 shared papers)David Planchard (3 shared papers)Anthony M. D’Amelio (3 shared papers)Pingkuan Zhang (2 shared papers)Harry J.M. Groen (3 shared papers)Bijoyesh Mookerjee (3 shared papers)
- Journals
- Blood (2 papers)British Journal of Haematology (1 paper)Journal of Clinical Oncology (1 paper)Journal of Thoracic Oncology (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Vanessa Giannone
11 papers receiving 1.2k citations
Vanessa Giannone's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 607
- Pulmonary and Respiratory Medicine 724
- Cancer Research 310
- Genetics 157
- Pathology and Forensic Medicine 211
Countries citing papers authored by Vanessa Giannone
This map shows the geographic impact of Vanessa Giannone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Giannone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Giannone more than expected).
Fields of papers citing papers by Vanessa Giannone
This network shows the impact of papers produced by Vanessa Giannone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Giannone. The network helps show where Vanessa Giannone may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanessa Giannone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial Hit paper breakdown → | 2017 | 948 |
| 2 | 2011 | 65 | |
| 3 | 2019 | 60 | |
| 4 | 2011 | 58 | |
| 5 | 2013 | 34 | |
| 6 | 2017 | 34 | |
| 7 | 2014 | 23 | |
| 8 | 2017 | 4 | |
| 9 | 2010 | 3 | |
| 10 | 2010 | 2 | |
| 11 | 2013 | 1 |
About Vanessa Giannone
Vanessa Giannone is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Organic Chemistry, Oncology and Epidemiology, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (4 papers), Lung Cancer Treatments and Mutations (4 papers), Iron Metabolism and Disorders (3 papers), Synthesis and biological activity (2 papers), Click Chemistry and Applications (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Lung Cancer Research Studies (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). The work is most often cited by research in Oncology (607 citations), Pulmonary and Respiratory Medicine (724 citations), Cancer Research (310 citations), Genetics (157 citations) and Pathology and Forensic Medicine (211 citations). Vanessa Giannone has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Benjamin Besse, Egbert F. Smit, Bruce E. Johnson, David Planchard, Anthony M. D’Amelio, Pingkuan Zhang, Harry J.M. Groen, Bijoyesh Mookerjee, Julien Mazières and Åslaug Helland. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Journal of Thoracic Oncology and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.